Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel ; volume:11 ; number:1 ; day:2 ; month:3 ; year:2018 ; pages:1-12 ; date:12.2018
Journal of hematology & oncology ; 11, Heft 1 (2.3.2018), 1-12, 12.2018
- Urheber
-
Porter, David
- Beteiligte Personen und Organisationen
-
Frey, Noelle
Wood, Patricia A.
Weng, Yanqiu
Grupp, Stephan A.
SpringerLink (Online service)
- DOI
-
10.1186/s13045-018-0571-y
- URN
-
urn:nbn:de:1111-201805083095
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Porter, David
- Frey, Noelle
- Wood, Patricia A.
- Weng, Yanqiu
- Grupp, Stephan A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cytokine release syndrome: grading, modeling, and new therapy
Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Cytokine release syndrome
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Cytokine release syndrome after bronchoalveolar lavage
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters
Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome
The Many Faces of Cytokine Release Syndrome-Related Coagulopathy
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma
First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer
Cytokine release syndrome: grading, modeling, and new therapy
Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Cytokine release syndrome
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Cytokine release syndrome after bronchoalveolar lavage
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters
Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome
The Many Faces of Cytokine Release Syndrome-Related Coagulopathy
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma
First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer
Cytokine release syndrome: grading, modeling, and new therapy
Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Cytokine release syndrome
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Cytokine release syndrome after bronchoalveolar lavage
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters
Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome
The Many Faces of Cytokine Release Syndrome-Related Coagulopathy
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma